There is a promising new drug for the rare disease mastocytosis, which is associated with skin lesions, among other things. Researchers at the University of Basel have now been able to use artificial ...

Symmetrical—lesions appear to be distributed in a similar arrangement on differing sides of the body (Figure 3, see slideshow) Once the configuration and distribution has been determined, the next ...

The Food and Drug Administration has authorized the first artificial intelligence-powered medical device to help doctors detect the most common forms of skin cancer in patients. The technology, from ...

Your skin is your largest organ, but it doesn’t get the attention it deserves—especially when it comes to skin checks for cancer. That should change, says Dr. Susan Massick, associate professor of ...

In my response to a related question, How Do I Differentiate Normal Aging of the Skin From Pathologic Conditions? I described some of the most common benign lesions that are encountered in geriatric ...

In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...

Now that the year is coming to an end, some people are looking in the mirror to reflect on what could be a possible new year’s resolution for 2024. Most people want to start off the new year by ...